Immunity Against Common Virus Leveraged Against Pancreatic Cancer
February 09, 2026
February 09, 2026
LA JOLLA, California, Feb. 9 -- The University of California San Diego campus posted the following news:
* * *
Immunity Against Common Virus Leveraged Against Pancreatic Cancer
*
"We were thrilled to see such a strong response in our preclinical studies, by delivering small pieces of viral proteins -CMV peptides -to pancreatic tumors, we were able to redirect the virus-specific T cells against the cancer cells," said co-senior author . . .
* * *
Immunity Against Common Virus Leveraged Against Pancreatic Cancer
*
"We were thrilled to see such a strong response in our preclinical studies, by delivering small pieces of viral proteins -CMV peptides -to pancreatic tumors, we were able to redirect the virus-specific T cells against the cancer cells," said co-senior author . . .